Long peripheral catheters for intravenous infusions of iloprost or alprostadil therapy in rheumatologic outpatients
The Journal of Vascular Access · 2025
DOI: 10.1177/11297298241252896 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Vascular Access, 2025. Verfasst von Mattia Donadoni und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Clinical Sciences "Luigi Sacco," University of Milan, Luigi Sacco Hospital, Milan, Italy. Hauptthemen laut MEDLINE: Iloprost, Alprostadil, Catheterization, Peripheral, Vasodilator Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Background
Long peripheral catheters (LPCs) role in Difficult IntraVenous Access (DIVA) patients admitted to the emergency department has already been studied, resulting in a rapid, safe, and cost-effective procedure. Although their use in outpatient settings is established, there is a lack of studies assessing their benefits. In particular, rheumatologic outpatients affected by scleroderma, especially those affected by digital ulcers, are often treated with intravenous infusions of prostaglandin I 2 (PGI 2 ) analog (IV-PGI 2 A). Objective and methods: From 1 October 2021 to 31 March 2024, we conducted a prospective study enrolling DIVA outpatients affected by systemic sclerosis or undifferentiated connective tissue disease who needed IV-PGI 2 A therapy at L. Sacco Hospital in Milan (Italy). Each treatment cycle consisted of four consecutive days of infusion of iloprost or alprostadil. The primary aim was to assess the efficacy and potential complications associated with LPCs for IV-PGI 2 A.
Results
Twenty-six patients were enrolled 23 were females (88.5%), and the median age was 72 years (IQR 56–78.7). In total, 97 LPCs were inserted, with a mean number of insertions per patient/year of 2.3. An increase in LPCs insertion during the 30 months of the enrollment period was observed. Eighteen patients required more than one LPC placement, and in 61% of them, the second venipuncture was executed at a different site. No procedural complications were registered (accidental puncture of the brachial artery, accidental median nerve puncture, bleeding) nor late complications (Catheter-Related Thrombosis, Catheter-Related Bloodstream Infections, Accidental Removal).
Conclusions
Our experience shows that LPCs could be valuable and safe for rheumatologic outpatients. The increased number of insertions and new and total patients enrolled each year defines the satisfaction of patients and health care professionals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical and Clinical Sciences "Luigi Sacco," University of Milan, Luigi Sacco Hospital, Milan, Italy.
- Department of Rheumatology, "Luigi Sacco" Hospital, Milan, Italy.
- Department of Infectious Diseases, "Luigi Sacco" Hospital, Milan, Italy.
ORCID-Profile: Antonio Gidaro
Zitieren
APA
Donadoni, M., Calloni, M., Romano, M. E., Mutti, A., Bartoli, A., La Cava, L., Celano, R., Urso, F., Popescu Janu, V., Foschi, A., Casella, F., Taino, A., Cogliati, C., Zappa, P., Masseroli, M. M., & Gidaro, A. (2025). Long peripheral catheters for intravenous infusions of iloprost or alprostadil therapy in rheumatologic outpatients. The Journal of Vascular Access. https://doi.org/10.1177/11297298241252896
Vancouver
Donadoni M, Calloni M, Romano ME, Mutti A, Bartoli A, La Cava L, et al. Long peripheral catheters for intravenous infusions of iloprost or alprostadil therapy in rheumatologic outpatients. The Journal of Vascular Access. 2025. doi:10.1177/11297298241252896
BibTeX
@article{Donadoni2025,
author = {Donadoni, Mattia and Calloni, Maria and Romano, Maria Eva and Mutti, Alessandra and Bartoli, Arianna and La Cava, Leyla and Celano, Rosita and Urso, Francesco and Popescu Janu, Valentina and Foschi, Antonella and Casella, Francesco and Taino, Alba and Cogliati, Chiara and Zappa, Paolo and Masseroli, Matteo Maria and Gidaro, Antonio},
title = {Long peripheral catheters for intravenous infusions of iloprost or alprostadil therapy in rheumatologic outpatients},
journal = {The Journal of Vascular Access},
year = {2025},
doi = {10.1177/11297298241252896}
}
EUVIMED